SGLT2 inhibitor — diabetes, heart failure, and CKD
Generic name: dapagliflozin
US Retail Price
$550–$650/month
With copay card: As low as $0–$10/month (commercially insured)
Manufacturer
AstraZeneca
Used For
Type 2 diabetes, heart failure (HFrEF and HFpEF), chronic kidney disease (CKD)
Generic dapagliflozin is not yet available in the US. AstraZeneca's patent protection is expected to last until approximately 2025–2027. The manufacturer savings card and international pharmacies offer the best savings currently.
AstraZeneca offers a savings card that can reduce Farxiga to as low as $0–$10/month for eligible commercially insured patients. Not valid for Medicare/Medicaid.
Apply for Farxiga Savings CardVerified international pharmacies sell Farxiga (dapagliflozin) for $60–$120/month — far less than US retail. Best option for Medicare patients.
Compare International PricesAstraZeneca offers patient assistance for those who meet income requirements. Search NeedyMeds for the Farxiga PAP application.
Search Farxiga PAP on NeedyMedsGoodRx coupons can reduce Farxiga costs at US pharmacies. Check GoodRx for the current lowest price near you.
Check GoodRx PriceLooking for another medication?
The Med Map covers all 8 categories of savings options for hundreds of drugs.
Back to The Med Map